
28/02/2023
This , Coslyte pays tribute to Indian Physicist C.V. Raman and salutes all the scientists who continue to make our lives easier and safer.
Fight dehydration and refresh your body instantly. Rehydrate Anywhere with Coslyte – an ideal ORS solution that meets WHO formulation standards.
Art Guild House B Wing Pheonix Market T Malll, L B S Marg
Mumbai
400070
Monday | 9am - 6pm |
Tuesday | 9am - 6pm |
Wednesday | 9am - 6pm |
Thursday | 9am - 6pm |
Friday | 9am - 6pm |
Saturday | 9am - 6pm |
Be the first to know and let us send you an email when ORSCoslyte posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Coslyte is a leading ORS brand in India, known for its WHO recommended formulation of 245 mOsm/L1 to fight dehydration instantly. With the right proportion of Sodium Chloride, Potassium Chloride, Sodium Citrate and Dextrose Anhydrous, Coslyte ORS replenishes the body with electrolytes, making it the ideal choice to combat diarrhoeal diseases and dehydration. Coslyte ORSpowder is available in 21gms and 4.2 grams sachets, in refreshing orange and lemon flavours, whereas Coslyte RTD is available in 200ml bottles in Orange Flavour.
It’s a brand of Oaknet Lifesciences which was launched in April 2015 by R S Raghav and a distinguished team of experts combining 150 years of experience, significant achievements & status amongst the top 10 pharma companies in the Indian Pharmaceutical Market (IPM).
In November 2016, Oaknet along with Investors acquired the Indian Operations of South African MNC Adcock Ingram Healthcare. Oaknet Healthcare Pvt Ltd enjoys an impressive market presence and a legacy of the Cosme Farma spanning close to four decades in such specialities as Dermatology, Gynaecology & Orthopaedics. With the acquisition of Adcock Ingram, Oaknet Healthcare became one of the fastest Indian Company to reach amongst the Top 100 Companies in the IPM.
Oaknet with tremendous leadership expertise in the IPM is poised to create history by scaling up revenues to INR 10 billion over the next 5 years through organic and inorganic growth. Specialities of focus are Cardiology, Diabetes, Dermatology, Gynaecology, Pain Management, Ophthalmology and Neurology.